Expectations for Vaccine Introduction and Uptake Across Global Health Markets: 2024 Benchmarking Analysis

The role of vaccines in global health has never been more prominent, offering life-saving protection against a variety of diseases. With over 20 vaccines available, they have averted millions of deaths and continue to be crucial in combating infectious diseases. Despite significant advancements in vaccine development and deployment, the global landscape reveals persistent challenges and disparities in achieving equitable vaccine access.

To address these disparities, a detailed understanding of vaccine introduction and uptake timelines is essential, especially for low-and middle-income countries. Recent analyses suggest that over the next decade, up to 14 new vaccines could be added to routine immunization schedules, increasing the burden on global health systems and markets.

Syneos Health, with research support from the Gates Foundation, conducted a comprehensive analysis focused on the timelines of vaccine introduction and uptake milestones across global health markets. This report provides data-backed estimates for future introductions, explores the impact of transitioning from universal to more targeted vaccines and expectations for uptake, and shares considerations for prioritization as new vaccines come to market.

Download the report for vital insights gathered for global health stakeholders aiming to enhance the efficiency of vaccine introduction processes and to improve access to life-saving vaccines across different regions.